QuidelOrtho Corporation (QDEL) key performance indicators and operating metrics (64 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted earnings before interest, taxes, depreciation and amortization | 129M | FY2026-Q2 |
| Respiratory revenue | 47.9M | FY2026-Q2 |
| Labs revenue | 382.95M | FY2026-Q2 |
| Point of Care revenue | 108.1M | FY2026-Q2 |
| Adjusted diluted earnings per share | 0.13 USD_per_share | FY2026-Q2 |
| Non-respiratory revenue | 583M | FY2026-Q2 |
| North America revenue growth | 5.80 percent | FY2026-Q2 |
| Labs revenue share | 57.00 percent | FY2026-Q1 |
| Point of Care revenue share | 18.00 percent | FY2026-Q1 |
| Recurring revenue | 689.1M | FY2025-Q4 |
| EMEA revenue | 91.2M | FY2026-Q2 |
| North America revenue | 327.4M | FY2026-Q2 |
| China revenue | 67.8M | FY2026-Q2 |
| Adjusted earnings before interest, taxes, depreciation and amortization margin | 20.50 percent | FY2026-Q2 |
Back to QDEL overview · QDEL earnings · QDEL holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.